BIZARRE: Nuvation bio - You Need To See This

Top 2 Health Care Stocks That May Plunge This Month

As of Sept. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga · Sep 5, 2025

Are These 2 'Strong Buy' Rated Growth Stocks Buys Right Now?

These two names could be long-term biotech plays for those willing to take the high-risk road.

Barchart · Jun 20, 2025

This Biotech Stock Insider is Buying Shares, Should You?

This Nuvation Bio board member and longtime biotech industry insider carried out his first purchase since his appointment in January.

Barchart · Oct 17, 2024

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

Upgrades

Benzinga · May 4, 2022

FDA clears Nuvation Bio's IND Application For NUV-868 In Advanced Solid Tumors

The 

Benzinga · Jan 20, 2022